Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Drug marketing (2)
- Medical research (2)
- Priority journal (2)
- Short survey (2)
- Academic acheivement (1)
-
- Aging (1)
- Annoyingly cheerful (1)
- Anxiety disorder (1)
- Attitude to health (1)
- Clinical medicine (1)
- Continuing education (1)
- Drug approval (1)
- Drug industry (1)
- Environmental factor (1)
- Environmental health (1)
- Evidence based medicine (1)
- Family history (1)
- Funding (1)
- Harm (1)
- Health care delivery (1)
- Health care policy (1)
- Health care quality (1)
- Health care system (1)
- Health economics (1)
- Health promotion (1)
- Health status (1)
- Human (1)
- Labeling (1)
- Medical decision making (1)
- Medical literature (1)
Articles 1 - 7 of 7
Full-Text Articles in Medicine and Health Sciences
Too Much Medicine, Not Enough Mirth, Ray Moynihan
Too Much Medicine, Not Enough Mirth, Ray Moynihan
Ray Moynihan
Extract:If there’s to be a global campaign to wind back overmedicalisation and iatrogenic illness, surely the best strategies include comedy and satire. The latest outbreak of satirical sanity comes from the US television comedian Stephen Colbert, who recently promoted the idea of “meducation,” a plan to use attention-deficit/hyperactivity disorder (ADHD) drugs to lift the school performance of healthy children.
Job Insecurity Contributes To Poor Health, Ray Moynihan
Job Insecurity Contributes To Poor Health, Ray Moynihan
Ray Moynihan
How do we create jobs that don't do more harm than good?
Has Novelty In Healthcare Gone A Little Stale?, Ray Moynihan
Has Novelty In Healthcare Gone A Little Stale?, Ray Moynihan
Ray Moynihan
Extract: Although drugs are essential, the roar of their marketing distorts decision making in favour of the newest and most expensive pills at the expense of older ones or of non-drug approaches. New diagnostic technologies offer undreamt of opportunities to detect ever earlier signs of illness, but they have also brought the increasingly recognised risk of overdiagnosis. Much has been written about how promotion can drive inappropriate use of valuable technologies, but does our deep love affair with novelty deserve more scrutiny?
The Dos And Don’Ts Of Collaborating With Industry, Ray Moynihan
The Dos And Don’Ts Of Collaborating With Industry, Ray Moynihan
Ray Moynihan
Extract: If you haven’t read the recent guidance on doctor-industry relationships, it’s certainly worth a look. Endorsed by leading professional groups, it argues that promising collaboration with industry “may be missed or even rejected” because of “misconceptions” arising from historical practices or rogue individuals. To set the record straight, the guidance emphasises the value of seeing sales representatives, the benefits of industry sponsored education, and the critical importance of health professionals serving on companies’ advisory boards.
Too Much Medicine; Too Little Care, Paul Glasziou, Ray Moynihan, Tessa Richards, Fiona Godlee
Too Much Medicine; Too Little Care, Paul Glasziou, Ray Moynihan, Tessa Richards, Fiona Godlee
Ray Moynihan
Extract: A growing frustration in clinical medicine is that we are now so busy managing the proliferation of risk factors, “incidentalomas,” and the worried well that we lack the time to care properly for those who are seriously ill. As the definitions of common conditions such as diabetes and kidney disease have expanded and the categories and boundaries of mental disorders have grown, our time and attention for the most worryingly ill, disturbed, and vulnerable patients has shrunk. Too much medicine is harming both the sick and well.
Reasons To Be Hopeful: Streams Of Renewal In Healthcare, Ray Moynihan
Reasons To Be Hopeful: Streams Of Renewal In Healthcare, Ray Moynihan
Ray Moynihan
Extract: The iconoclastic former BMJ editor Richard Smith has mused that medicine might need to feel utterly defeated for it to undergo much needed radical renewal.1 Whether or not defeat is imminent, a culture shift is being debated,2 and renewal is inevitable. The current medical-industrial paradigm—fragmented, technocratic, mechanistic, inhuman, and imperial—is neither healthy nor sustainable. While there’s much that is hopeful in debates about clinical medicine, public health, and beyond, I’d like to identify 10 streams of change that may ultimately coalesce to form a coherent vision of radical renewal.
Expanding Disease Definitions In Guidelines And Expert Panel Ties To Industry: A Cross-Sectional Study Of Common Conditions In The United State, Ray Moynihan, Georga Cooke, Jenny Doust, Lisa Bero, Suzanne Hill, Paul Glasziou
Expanding Disease Definitions In Guidelines And Expert Panel Ties To Industry: A Cross-Sectional Study Of Common Conditions In The United State, Ray Moynihan, Georga Cooke, Jenny Doust, Lisa Bero, Suzanne Hill, Paul Glasziou
Ray Moynihan
Financial ties between health professionals and industry may unduly influence professional judgments and some researchers have suggested that widening disease definitions may be one driver of over-diagnosis, bringing potentially unnecessary labeling and harm. We aimed to identify guidelines in which disease definitions were changed, to assess whether any proposed changes would increase the numbers of individuals considered to have the disease, whether potential harms of expanding disease definitions were investigated, and the extent of members' industry ties.